Back to Search
PETER JONES, M.D.
M.D.
Internal Medicine Physician
NPI: 1336197623Individual
Specialties, Licenses & Credentials
Internal Medicine PhysicianPrimary
Internal Medicine
Code: 207R00000X
E8600(TX)
Clinical Trials (1)
1
Linked Trials
0
Recruiting
0
With Results
Research & Publications (20)
Lathosterol-to-cholesterol ratio in serum predicts cholesterol-lowering response to plant sterol consumption in a dual-center, randomized, single-blind placebo-controlled trial.
PMID 25733626·Am J Clin Nutr·2015
4-observational
CYP7A1-rs3808607 and APOE isoform associate with LDL cholesterol lowering after plant sterol consumption in a randomized clinical trial.
PMID 26333513·Am J Clin Nutr·2015
4-observational
Efficacy and safety of ABT-335 (fenofibric acid) in combination with rosuvastatin in patients with mixed dyslipidemia: a phase 3 study.
PMID 18996523·Atherosclerosis·2009
3-trial
Adjunctive interventions in myocardial infarction: the role of statin therapy.
PMID 18417069·Curr Atheroscler Rep·2008
6-review
Evaluation of a new formulation of fenofibric acid, ABT-335, co-administered with statins : study design and rationale of a phase III clinical programme.
PMID 18783301·Clin Drug Investig·2008
3-trial
Expert perspective: reducing cardiovascular risk in metabolic syndrome and type 2 diabetes mellitus beyond low-density lipoprotein cholesterol lowering.
PMID 19084089·Am J Cardiol·2008
6-review
Clinical significance of recent lipid trials on reducing risk in patients with type 2 diabetes mellitus.
PMID 17307065·Am J Cardiol·2007
6-review
Lipids: new guidelines, intensive treatment, and future directions.
PMID 16878620·Tex Heart Inst J·2006
8-other
Rationale for intensive statin treatment in high-risk patients.
PMID 16603827·Prev Cardiol·2006
6-review
Statins: the case for higher, individualized starting doses.
PMID 16193828·Cleve Clin J Med·2005
6-review
Comparison of the efficacy and safety of atorvastatin initiated at different starting doses in patients with dyslipidemia.
PMID 15660024·Am Heart J·2005
3-trial
Reporting rate of rhabdomyolysis with fenofibrate + statin versus gemfibrozil + any statin.
PMID 15619408·Am J Cardiol·2005
4-observational
Effects of rosuvastatin versus atorvastatin, simvastatin, and pravastatin on non-high-density lipoprotein cholesterol, apolipoproteins, and lipid ratios in patients with hypercholesterolemia: additional results from the STELLAR trial.
PMID 15531001·Clin Ther·2004
3-trial
Low-density lipoprotein cholesterol reduction and cardiovascular disease prevention: the search for superior treatment.
PMID 15050188·Am J Med·2004
6-review
Statins as the cornerstone of drug therapy for dyslipidemia: monotherapy and combination therapy options.
PMID 15211327·Am Heart J·2004
8-other
Atherosclerosis target of lipid-lowering therapy: is lower LDL cholesterol better?
PMID 13678393·Am J Manag Care·2003
8-other
Comparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvastatin, and pravastatin across doses (STELLAR* Trial).
PMID 12860216·Am J Cardiol·2003
3-trial
Achieving cholesterol goals. Current and future drug therapies.
PMID 19667635·Postgrad Med·2003
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 6565 FANNIN ST, A601
HOUSTON, TX 77030 - Phone
- (713) 790-5800
Quick Facts
- NPI
- 1336197623
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Clinical Trials
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile